Comparison between Curcumin and Lycopene in Management of Oral Submucous Fibrosis in Terms of Burning Sensation and Mouth Opening
DOI:
https://doi.org/10.70749/ijbr.v3i4.2464Keywords:
Oral submucous fibrosis, Curcumin, Lycopene, Burning sensation, Mouth opening, AntioxidantsAbstract
Background & Objective: Oral submucous fibrosis (OSMF) is a chronic, potentially malignant condition characterized by burning sensation and progressive limitation of mouth opening. Curcumin and lycopene are natural antioxidants explored for their therapeutic benefits in OSMF. The objective of our study was to compare curcumin and lycopene in treatment of oral submucus fibrosis in terms of mean mouth opening and mean burning sensation. Methodology: This comparative cross-sectional study was conducted at the Department of Oral and Maxillofacial Surgery, Allied Hospital, Faisalabad. Sixty patients diagnosed with OSMF were randomly assigned into two groups: Group A received lycopene (10 mg twice daily), while Group B received curcumin (500 mg thrice daily) for six weeks. Pre- and post-treatment assessments of burning sensation (using VAS score) and mouth opening (in centimeters) were performed. Results: Baseline characteristics were comparable except for gender (more males in Group B, p = 0.008) and Gutka use (higher in Group A, p = 0.028). Group A (Lycopene) showed significantly greater improvement in burning sensation (p = 0.027) and mouth opening (start: p = 0.022; end: p < 0.001). Conclusion: Both curcumin and lycopene are effective in the management of OSMF. Curcumin offers superior symptomatic relief, while lycopene shows greater improvement in mouth opening. Combination therapy may enhance therapeutic outcomes and warrants further investigation.
Downloads
References
1. Mostafa MG, Khan JA, Ahmed S, Kamruzzaman M, Islam MR, Rahman MA, et al. Comparison between efficacy of combined use of hyaluronidise and triamcinolone versus hyaluronidise, triamcinolone acetonide and oral colchicine in the treatment of oral submucous fibrosis. Mymensingh Med J. 2021;30(1):79-84.
2. Memon A, Shahid H, Shafique S. Oral submucous fibrosis; comparison of efficacy between clobetasol and triamcinolone application in oral submucous fibrosis patients with burning sensation. Professional Med J. 2018;25(7):1005-12.
https://doi.org/10.29309/tpmj/18.4408
3. Rai A, Kumar N, Sharma S, Parveen S, Rasheed A. Turmeric in the management of oral submucous fibrosis: A systematic review and meta-analysis. J Can Res Ther. 2021;17:327-35.
https://doi.org/10.4103/jcrt.jcrt_95_20
4. Warnakulasuriya S, Chen THH. Areca nut and oral cancer: evidence from studies conducted in humans. J Dent Res. 2022;101(10):1139-46.
https://doi.org/10.1177/00220345221092751
5. Shih Y-H, Wang T-H, Shieh T-M, Tseng Y-H. Oral submucous fibrosis: a review on etiopathogenesis, diagnosis, and therapy. Int J Mol Sci. 2019;20(12):2940.
https://doi.org/10.3390/ijms20122940
6. Gupta N, Kalaskar A, Kalaskar R. Efficacy of lycopene in management of oral submucous fibrosis– a systematic review and meta-analysis. J Oral Biol Craniofac Res. 2020;10(4):690-7.
https://doi.org/10.1016/j.jobcr.2020.09.004
7. Guo J, Xie H, Wu H, Liang M. Efficacy of lycopene in the treatment of oral submucous fibrosis: a meta-analysis of randomized controlled trials. J Evid Based Dent Pract. 2020;20(4):101471.
https://doi.org/10.1016/j.jebdp.2020.101471
8. Saran G, Umapathy D, Misra N, Channaiah SG, Singh P, Srivastava S, Shivakumar S. A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: a randomized clinical trial. Indian J Dent Res. 2018;29:303-12.
https://doi.org/10.4103/ijdr.ijdr_551_16
9. Rai A, Kaur M, Gombra V, Hasan S, Kumar N. Comparative evaluation of curcumin and antioxidants in the management of oral submucous fibrosis. J Investig Clin Dent. 2019;10(4):e12464.
https://doi.org/10.1111/jicd.12464
10. Sanika S, Pawar SR, Patil S, et al. Evaluation of the therapeutic efficacy of lycopene and curcumin in oral submucous fibrosis: a comparative clinical study. J Contemp Dent Pract. 2022;23(2):159-63.
11. Ghosh S, Roy R, Das S, et al. Comparative assessment of efficacy of lycopene and curcumin in patients with oral submucous fibrosis. Asian Pac J Health Sci. 2022;9(1):284-288.
12. Reddy CR, Basha SK, Kattimani V, et al. Comparative evaluation of the therapeutic response of lycopene and curcumin in oral submucous fibrosis: A randomized controlled trial. Asian Pac J Cancer Prev. 2021;22(9):2897-2904.
https://doi.org/10.31557/APJCP.2021.22.9.2897
13. Gan RY, Li HB, Song FL, Kuang L, Li HQ. Dietary lycopene: A promising natural compound for oral submucous fibrosis and associated inflammation and oxidative stress. Front Pharmacol. 2024;15:1478170.
https://doi.org/10.3389/fphar.2024.1478170
14. Gopinath D, Prabhu S, Jeyaseelan L, et al. Comparative effectiveness of different interventions in oral submucous fibrosis: A systematic review and network meta-analysis. J Pers Med. 2022;12(8):1272.
https://doi.org/10.3390/jpm12081272
15. Kopuri RK, et al. Comparative analysis of curcumin and lycopene using ultrasonography in oral submucous fibrosis. J Clin Diagn Res. 2016;10(11):ZC76-ZC79.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
